| Literature DB >> 32121556 |
Sheldon R Lawrence1,2, Meghan Gaitens2, Qijie Guan2, Craig Dufresne3, Sixue Chen1,2,4.
Abstract
Nitric oxide (NO) plays an important role in stomata closure induced by environmental stimuli including pathogens. During pathogen challenge, nitric oxide (NO) acts as a second messenger in guard cell signaling networks to activate downstream responses leading to stomata closure. One means by which NO's action is achieved is through the posttranslational modification of cysteine residue(s) of target proteins. Although the roles of NO have been well studied in plant tissues and seedlings, far less is known about NO signaling and, more specifically, protein S-nitrosylation (SNO) in stomatal guard cells. In this study, using iodoTMTRAQ quantitative proteomics technology, we analyzed changes in protein SNO modification in guard cells of reference plant Arabidopsis thaliana in response to flg22, an elicitor-active peptide derived from bacterial flagellin. A total of 41 SNO-modified peptides corresponding to 35 proteins were identified. The proteins cover a wide range of functions, including energy metabolism, transport, stress response, photosynthesis, and cell-cell communication. This study creates the first inventory of previously unknown NO responsive proteins in guard cell immune responses and establishes a foundation for future research toward understanding the molecular mechanisms and regulatory roles of SNO in stomata immunity against bacterial pathogens.Entities:
Keywords: Arabidopsis thaliana; flg22; iodoTMTRAQ; nitric oxide; redox proteomics; stomatal immunity
Year: 2020 PMID: 32121556 PMCID: PMC7084773 DOI: 10.3390/ijms21051688
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Stomatal guard cell purity and viability before and after the removal of mesophyll and epidermal cells. Neutral red viability staining of epidermal peels: (A) before digestion and (B) after digestion. FDA viability staining of the peels: (C) before digestion and (D) 60 min after digestion. Scale bar: 30 µm.
Figure 2Stomatal movement in response to 10 μM flg22. Data were obtained from 180 stomata from three independent experiments and presented as means ± SE. Different letters indicate significantly different mean values at p < 0.05.
Figure 3Reactive oxygen species (ROS) sproduction in guard cells in response to 10 μM flg22. (A) ROS levels measured from a total of 180 stomata from three independent experiments and presented as means ± SE. Different letters indicate significantly different mean values at p < 0.05. (B) Representative images of stomatal guard cells at each time point are shown. Scale bar: 10 µm.
Figure 4Guard cell nitric oxide (NO) levels in response to 10 µM flg22. (A) NO levels measured from a total of 180 stomata from three independent experiments and presented as means ± SE. Different letters indicate significantly different mean values at p < 0.05. (B) Representative images of stomatal guard cells at each time point are shown. Scale bar: 10 µm.
S-nitrosylated proteins identified in guard cells after flg22 treatment for 15 min, 30 min and 60 min. The tick under DiANNA indicates the predicted cysteine residue involved in disulfide bond formation.
| Protein Accession | Peptide | Protein Description | Fold | Biological Function | DiANNA | |
|---|---|---|---|---|---|---|
|
| ||||||
| AT2G10940.1 | NPPPGYT | Lipid-transfer protein (LTP) II | 4.72 | 0.016 | Lipid binding | √ |
| AT2G10940.1 | AT | LTP II | 4.67 | 0.025 | Lipid binding | √ |
| AT3G23810.1 | FDNLYG | S-adenosyl-L-homocysteine hydrolase 2 (SAHH2) | 3.29 | 0.024 | Carbon metabolic process | √ |
| AT3G44310.2 | IGAAI | Nitrilase (NIT) 1 | 3.18 | 0.003 | Nitrogen compound metabolic process | √ |
| AT3G08560.1 | IV | Vacuolar H+-ATPase (VHA) E2 | 2.94 | 0.001 | Hydrogen ion transport | √ |
| AT1G78830.1 | Curculin-like lectin protein (CLP) | 1.91 | 0.020 | Response to cytokinin, Stress response | √ | |
| AT1G78850.1 | GLLGWDET | Mannose binding lectin (MBL) 1 | 1.90 | 0.010 | Mannose binding | √ |
| AT1G78850.1 | SPSLAS | MBL 1 | 1.67 | 0.039 | Mannose binding | √ |
| AT5G54270.1 | WAMLGAFG | Chlorophyll a-b binding protein (CBP) 3 | 1.48 | 0.032 | Photosynthesis | − |
|
| ||||||
| AT2G10940.1 | NPPPGYT | LTP II | 2.22 | 0.005 | Lipid binding | √ |
| AT5G17220.1 | LYGQVTAA | Glutathione S-transferase (GST) phi 12 | 1.53 | 0.049 | Nitrogen compound metabolism, Stress response | √ |
| AT1G26850.3 | S-adenosyl-L-methionine- methyltransferase (SAMMT) | 0.64 | 0.035 | Methylation | √ | |
| AT5G54270.1 | WAMLGAFG | CBP 3 | 0.57 | 0.047 | Photosynthesis | − |
| AT1G78850.1 | GLLGWDET | MBL1 | 0.55 | 0.023 | Mannose binding | √ |
| AT1G65590.1 | VVPFEPGS | Beta-hexosaminidase (HAD) 3 | 0.54 | 0.021 | Lipid metabolic process | √ |
| AT3G01500.1 | V | Beta-carbonic anhydrase (CA) 1 | 0.49 | 0.047 | Carbon utilization, Stress response | √ |
| AT4G39710.1 | SGLGF | FK506-binding protein (FKBP) 16-2 | 0.43 | 0.012 | Photosynthesis | √ |
| AT5G63800.1 | SPDAPDPVINT | Beta-galactosidase (GALD) 6 | 0.38 | 0.035 | Carbohydrate metabolism | √ |
| AT3G52500.1 | YL | Aspartyl protease (APP) | 0.30 | 0.039 | Cellular process | √ |
| AT4G28520.3 | VVPG | Cruciferin (CRU) 3 | 0.15 | 0.045 | Response to abscisic acid | √ |
| AT5G44120.3 | VIPG | CRU 1 | 0.10 | 0.027 | Response to abscisic acid | √ |
| NIT 1 | 6.31 | 0.049 | Nitrogen compound metabolic process | √ | ||
| AT3G23810.1 | FDNLYG | SAHH2 | 3.29 | 0.024 | Cysteine and methionine metabolism | √ |
| AT4G11150.1 | IV | VHA E1 | 2.55 | 0.003 | ATP synthesis | √ |
| AT2G05520.1 | QGGGGSGGSY | Glycine-rich protein (GRP) 3 | 2.12 | 0.028 | Stress response | √ |
| ATCG01060.1 | PSI PsaC subunit | 2.11 | 0.031 | Photosynthesis | √ | |
| AT5G38410.3 | QVQ | Ribulose bisphosphate carboxylase (Rubisco) small chain (RBCS) | 2.03 | 0.049 | Photosynthesis | √ |
| AT2G30970.1 | IAAVQTLSGTGA | Aspartate aminotransferase (APAT)1 | 1.99 | 0.023 | Amino acid metabolic process | √ |
| AT2G21060.1 | E | GRP 2 | 1.96 | 0.030 | Stress response | √ |
| AT3G62940.3 | LKPLGLTVSEIKPDGH | Cysteine proteinase (CP) | 1.91 | 0.008 | - | √ |
| AT5G16390.1 | QLD | Acetylcoenzyme A carboxylase (AAC) 1 | 1.71 | 0.001 | Fatty acid biosynthetic process | √ |
| ATCG00490.1 | VALEA | Rubisco Large chain (RBCL) | 1.71 | 0.019 | Photosynthesis | √ |
| AT2G20360.1 | YIQVS | NAD (P)-binding protein (NBP) | 1.45 | 0.018 | Electron transport, Stress response | − |
| AT5G08680.1 | ATP synthase subunit (ASS) beta-3 | 1.45 | 0.046 | ATP synthesis | − | |
| AT5G23890.1 | VIETDTQPSDL | Unknown protein (UNK) | 1.45 | 0.007 | − | √ |
| AT3G09820.1 | AG | Adenosine kinase (ADK) 1 | 1.42 | 0.010 | Purine metabolism, response to stimuli | √ |
| AT5G03340.1 | YTQGFSGADITEICQR | Cell division cycle (CDC) 48 | 1.30 | 0.041 | Protein transport, cell division | √ |
| AT4G13010.1 | LANAHVTATCGAR | Oxidoreductase (OR) | 1.28 | 0.046 | Oxidation and reduction | √ |
| AT1G42970.1 | TNPADEE | Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) B | 0.79 | 0.031 | Glucose metabolism, Oxidation and reduction | √ |
| AT5G36700.1 | ENPG | 2-phosphoglycolate phosphatase (PGP) 1 | 0.76 | 0.043 | Photorespiration | √ |
| AT3G01500.3 | YMVFA | CA 1 | 0.69 | 0.021 | Carbon utilization | − |
| AT5G14740.1 | VLAESESSAFEDQ | CA 2 | 0.69 | 0.007 | Carbon utilization | − |
Figure 5Gene ontology analysis of the redox proteins after flg22 treatment. Relevant biological processes are shown on the y-axis. Number of proteins significantly redox-regulated at each time point after treatment is shown on the x-axis.
Figure 6Annotated mass spectrum of a representative cysteine-containing peptide (C8-iodoTMT) showing differential redox status from control and treated samples. The MS/MS ions used to identify the peptide were labeled, and the intensity of the individual iodoTMT peaks for quantification was inserted in the upper left corner. This peptide is one of two that was used to identify lipid-transfer protein isoform II as a potential NO regulated protein.
Figure 7Heat-map of 35 nitrosylated proteins obtained by hierarchical clustering. The columns represent different time point ratios of treatment/control. The rows represent individual proteins. Protein AGI numbers are listed to the right. The increased and decreased proteins are represented in red or green, respectively. The color intensity increases with increasing differences, as shown in the scale bar. Please refer to Table 1 for detailed information.